Swati Rane1, Natalie Koh2, John Oakley3, Christina Caso2, Cyrus P Zabetian4, Brenna Cholerton5, Thomas J Montine5, Thomas Grabowski2. 1. Integrated Brain Imaging Center, Radiology, University of Washington Medical Center, Seattle, WA, USA. Electronic address: srleven@uw.edu. 2. Integrated Brain Imaging Center, Radiology, University of Washington Medical Center, Seattle, WA, USA. 3. Department of Neurology, University of Washington Medical Center, Seattle, WA, USA. 4. Department of Neurology, University of Washington Medical Center, Seattle, WA, USA; Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA. 5. Department of Pathology, Stanford University, Stanford, CA, 94305, USA.
Abstract
INTRODUCTION: Imaging neurovascular disturbances in Parkinson's disease (PD) is an excellent measure of disease severity. Indeed, a disease-specific regional pattern of abnormal metabolism has been identified using positron emission tomography. Only a handful of studies, however, have applied perfusion MRI to detect this disease pattern. Our goal was to replicate the evaluation of a PD-related perfusion pattern using scaled subprofile modeling/principal component analysis (SSM-PCA). METHODS: We applied arterial spin labeling (ASL) MRI for this purpose. Uniquely, we assessed this pattern separately in PD individuals ON and OFF dopamine medications. We further compared the existence of these patterns and their strength in each individual with their Movement Disorder Society-Unified Parkinson's Disease Rating Scale motor (MDS-UPDRS) scores, cholinergic tone as indexed by short-term afferent inhibition (SAI), and other neuropsychiatric tests. RESULTS: We observed a PD-related perfusion pattern that was similar to previous studies. The patterns were observed in both ON and OFF states but only the pattern in the OFF condition could significantly (AUC=0.72) differentiate between PD and healthy subjects. In the ON condition, PD subjects were similar to controls from a CBF standpoint (AUC=0.45). The OFF pattern prominently included the posterior cingulate, precentral region, precuneus, and the subcallosal cortex. Individual principal components from the ON and OFF states were strongly associated with MDS-UPDRS scores, SAI amplitude and latency. CONCLUSION: Using ASL, our study identified patterns of abnormal perfusion in PD and were associated with disease symptoms.
INTRODUCTION: Imaging neurovascular disturbances in Parkinson's disease (PD) is an excellent measure of disease severity. Indeed, a disease-specific regional pattern of abnormal metabolism has been identified using positron emission tomography. Only a handful of studies, however, have applied perfusion MRI to detect this disease pattern. Our goal was to replicate the evaluation of a PD-related perfusion pattern using scaled subprofile modeling/principal component analysis (SSM-PCA). METHODS: We applied arterial spin labeling (ASL) MRI for this purpose. Uniquely, we assessed this pattern separately in PD individuals ON and OFF dopamine medications. We further compared the existence of these patterns and their strength in each individual with their Movement Disorder Society-Unified Parkinson's Disease Rating Scale motor (MDS-UPDRS) scores, cholinergic tone as indexed by short-term afferent inhibition (SAI), and other neuropsychiatric tests. RESULTS: We observed a PD-related perfusion pattern that was similar to previous studies. The patterns were observed in both ON and OFF states but only the pattern in the OFF condition could significantly (AUC=0.72) differentiate between PD and healthy subjects. In the ON condition, PD subjects were similar to controls from a CBF standpoint (AUC=0.45). The OFF pattern prominently included the posterior cingulate, precentral region, precuneus, and the subcallosal cortex. Individual principal components from the ON and OFF states were strongly associated with MDS-UPDRS scores, SAI amplitude and latency. CONCLUSION: Using ASL, our study identified patterns of abnormal perfusion in PD and were associated with disease symptoms.
Authors: Jan Petr; Henri J M M Mutsaerts; Enrico De Vita; Rebecca M E Steketee; Marion Smits; Aart J Nederveen; Frank Hofheinz; Jörg van den Hoff; Iris Asllani Journal: MAGMA Date: 2018-06-18 Impact factor: 2.310
Authors: Martina Mancini; Brett W Fling; Anne Gendreau; Jodi Lapidus; Fay B Horak; Kathy Chung; John G Nutt Journal: BMC Neurol Date: 2015-12-23 Impact factor: 2.474
Authors: Zuzana Nedelska; Matthew L Senjem; Scott A Przybelski; Timothy G Lesnick; Val J Lowe; Bradley F Boeve; Arvin Arani; Prashanthi Vemuri; Jonathan Graff-Radford; Tanis J Ferman; David T Jones; Rodolfo Savica; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: Neuroimage Clin Date: 2018-06-19 Impact factor: 4.881